Testing effectiveness (Phase 2)Study completedNCT04328077
What this trial is testing
LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)
Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 101